Tectonic Therapeutic Files DEF 14A

Ticker: TECX · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1681087

Tectonic Therapeutic, Inc. DEF 14A Filing Summary
FieldDetail
CompanyTectonic Therapeutic, Inc. (TECX)
Form TypeDEF 14A
Filed DateApr 25, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, executive-compensation

TL;DR

Tectonic (formerly AVROBIO) filed its annual proxy statement. All eyes on exec comp.

AI Summary

Tectonic Therapeutic, Inc. filed its DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Notably, the company was formerly known as AVROBIO, Inc. before changing its name on January 31, 2018.

Why It Matters

This filing provides transparency into the company's executive compensation and governance, which can influence investor confidence and decision-making.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) that primarily concerns corporate governance and executive compensation, not immediate operational or financial risks.

Key Players & Entities

  • Tectonic Therapeutic, Inc. (company) — Filer
  • AVROBIO, Inc. (company) — Former company name
  • 20250425 (date) — Filing date
  • 2024-12-31 (date) — Fiscal year end

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.

When was Tectonic Therapeutic, Inc. formerly known as AVROBIO, Inc.?

Tectonic Therapeutic, Inc. was formerly known as AVROBIO, Inc. until January 31, 2018.

What is the fiscal year end for Tectonic Therapeutic, Inc.?

The fiscal year end for Tectonic Therapeutic, Inc. is December 31.

What is the filing date of this DEF 14A?

This DEF 14A filing was made on April 25, 2025.

What industry does Tectonic Therapeutic, Inc. operate in?

Tectonic Therapeutic, Inc. operates in the Biological Products (no diagnostic substances) industry, SIC code 2836.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Tectonic Therapeutic, Inc. (TECX).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.